{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:04:20Z","timestamp":1773281060459,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s13577-021-00623-y","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T11:09:01Z","timestamp":1633000141000},"page":"125-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Addition of ROCK inhibitors to prostaglandin derivative (PG) synergistically affects adipogenesis of the 3D spheroids of human orbital fibroblasts (HOFs)"],"prefix":"10.1007","volume":"35","author":[{"given":"Fumihito","family":"Hikage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanae","family":"Ichioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Araya","family":"Umetsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ohguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5165-6507","authenticated-orcid":false,"given":"Yosuke","family":"Ida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"623_CR1","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1523\/JNEUROSCI.3931-04.2005","volume":"25","author":"J Bertrand","year":"2005","unstructured":"Bertrand J, Winton MJ, Rodriguez-Hernandez N, Campenot RB, McKerracher L. Application of Rho antagonist to neuronal cell bodies promotes neurite growth in compartmented cultures and regeneration of retinal ganglion cell axons in the optic nerve of adult rats. J Neurosci. 2005;25:1113\u201321. https:\/\/doi.org\/10.1523\/JNEUROSCI.3931-04.2005.","journal-title":"J Neurosci"},{"key":"623_CR2","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3980\/j.issn.2222-3959.2011.06.16","volume":"4","author":"H-B Tan","year":"2011","unstructured":"Tan H-B, Zhong Y-S, Cheng Y, Shen X. Rho\/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damage. Int J Ophthalmol. 2011;4:652\u20137. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2011.06.16.","journal-title":"Int J Ophthalmol"},{"key":"623_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10384-011-0048-9","volume":"55","author":"H Watabe","year":"2011","unstructured":"Watabe H, Abe S, Yoshitomi T. Effects of Rho-associated protein kinase inhibitors Y-27632 and Y-39983 on isolated rabbit ciliary arteries. Jpn J Ophthalmol. 2011;55:411\u20137. https:\/\/doi.org\/10.1007\/s10384-011-0048-9.","journal-title":"Jpn J Ophthalmol"},{"key":"623_CR4","first-page":"251","volume":"10","author":"JM Stiles","year":"2013","unstructured":"Stiles JM, Kurisetty V, Mitchell DC, Bryan BA. Rho kinase proteins regulate global mirna expression in endothelial cells. Cancer Genomics - Proteomics. 2013;10:251\u201363.","journal-title":"Cancer Genomics - Proteomics"},{"key":"623_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0014-5793(96)00811-3","volume":"392","author":"O Nakagawa","year":"1996","unstructured":"Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine\/threonine kinase in mice. FEBS Lett. 1996;392:189\u201393. https:\/\/doi.org\/10.1016\/0014-5793(96)00811-3.","journal-title":"FEBS Lett"},{"key":"623_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1006\/bbrc.2001.5751","volume":"288","author":"C Fukiage","year":"2001","unstructured":"Fukiage C, Mizutani K, Kawamoto Y, Azuma M, Shearer TR. Involvement of phosphorylation of myosin phosphatase by ROCK in trabecular meshwork and ciliary muscle contraction. Biochem Biophys Res Commun. 2001;288:296\u2013300. https:\/\/doi.org\/10.1006\/bbrc.2001.5751.","journal-title":"Biochem Biophys Res Commun"},{"key":"623_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s10384-007-0471-0","volume":"51","author":"T Yokota","year":"2007","unstructured":"Yokota T, Utsunomiya K, Taniguchi K, Gojo A, Kurata H, Tajima N. Involvement of the Rho\/Rho kinase signaling pathway in platelet-derived growth factor BB-induced vascular endothelial growth factor expression in diabetic rat retina. Jpn J Ophthalmol. 2007;51:424\u201330. https:\/\/doi.org\/10.1007\/s10384-007-0471-0.","journal-title":"Jpn J Ophthalmol"},{"key":"623_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2337\/db08-0762","volume":"58","author":"R Arita","year":"2009","unstructured":"Arita R, Hata Y, Nakao S, Kita T, Miura M, Kawahara S, Zandi S, Almulki L, Tayyari F, Shimokawa H, et al. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage. Diabetes. 2009;58:215\u201326. https:\/\/doi.org\/10.2337\/db08-0762.","journal-title":"Diabetes"},{"key":"623_CR9","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1167\/iovs.14-15681","volume":"56","author":"K Hollanders","year":"2015","unstructured":"Hollanders K, Van Bergen T, Kindt N, Castermans K, Leysen D, Vandewalle E, Moons L, Stalmans I. The effect of AMA0428, a novel and potent ROCK inhibitor, in a model of neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2015;56:1335\u201348. https:\/\/doi.org\/10.1167\/iovs.14-15681.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"623_CR10","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1097\/ICO.0b013e3182281ee1","volume":"30","author":"N Okumura","year":"2011","unstructured":"Okumura N, Koizumi N, Ueno M, Sakamoto Y, Takahashi H, Hamuro J, Kinoshita S. The new therapeutic concept of using a Rho kinase inhibitor for the treatment of corneal endothelial dysfunction. Cornea. 2011;30:S54\u20139. https:\/\/doi.org\/10.1097\/ICO.0b013e3182281ee1.","journal-title":"Cornea"},{"key":"623_CR11","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1167\/iovs.11-8018","volume":"53","author":"T Kameda","year":"2012","unstructured":"Kameda T, Inoue T, Inatani M, Fujimoto T, Honjo M, Kasaoka N, Inoue-Mochita M, Yoshimura N, Tanihara H. The effect of Rho-associated protein kinase inhibitor on Monkey Schlemm\u2019s canal endothelial cells. Invest Ophthalmol Vis Sci. 2012;53:3092\u2013103. https:\/\/doi.org\/10.1167\/iovs.11-8018.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"623_CR12","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1167\/iovs.13-13157","volume":"55","author":"S Van de Velde","year":"2014","unstructured":"Van de Velde S, Van Bergen T, Sijnave D, Hollanders K, Castermans K, Defert O, Leysen D, Vandewalle E, Moons L, Stalmans I. AMA0076, a novel, locally acting Rho Kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia. Invest Ophthalmol Vis Sci. 2014;55:1006\u201316. https:\/\/doi.org\/10.1167\/iovs.13-13157.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"623_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2013.05.002","volume":"37","author":"T Inoue","year":"2013","unstructured":"Inoue T, Tanihara H. Rho-associated kinase inhibitors: a novel glaucoma therapy. Prog Retin Eye Res. 2013;37:1\u201312. https:\/\/doi.org\/10.1016\/j.preteyeres.2013.05.002.","journal-title":"Prog Retin Eye Res"},{"key":"623_CR14","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1111\/aos.12599","volume":"93","author":"H Tanihara","year":"2015","unstructured":"Tanihara H, Inoue T, Yamamoto T, Kuwayama Y, Abe H, Suganami H, Araie M, Group, t.K.-C.S. Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24\u00a0hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study. Acta Ophthalmol. 2015;93:e254\u201360.","journal-title":"Acta Ophthalmol"},{"key":"623_CR15","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/01.opx.0000141791.16683.4a","volume":"81","author":"LS Peplinski","year":"2004","unstructured":"Peplinski LS, Albiani Smith K. Deepening of lid sulcus from topical bimatoprost therapy. Optom Vis Sci. 2004;81:574\u20137.","journal-title":"Optom Vis Sci"},{"key":"623_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1006\/bbrc.1997.6433","volume":"233","author":"G Serrero","year":"1997","unstructured":"Serrero G, Lepak NM. Prostaglandin F2alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium. Biochem Biophys Res Commun. 1997;233:200\u20132. https:\/\/doi.org\/10.1006\/bbrc.1997.6433.","journal-title":"Biochem Biophys Res Commun"},{"key":"623_CR17","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.1038\/s41598-020-64674-1","volume":"10","author":"Y Ida","year":"2020","unstructured":"Ida Y, Hikage F, Itoh K, Ida H, Ohguro H. Prostaglandin F2alpha agonist-induced suppression of 3T3-L1 cell adipogenesis affects spatial formation of extra-cellular matrix. Sci Rep. 2020;10:7958. https:\/\/doi.org\/10.1038\/s41598-020-64674-1.","journal-title":"Sci Rep"},{"key":"623_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/iovs.61.6.13","volume":"61","author":"K Itoh","year":"2020","unstructured":"Itoh K, Hikage F, Ida Y, Ohguro H. Prostaglandin F2alpha agonists negatively modulate the size of 3D organoids from primary human orbital fibroblasts. Invest Ophthalmol Vis Sci. 2020;61:13. https:\/\/doi.org\/10.1167\/iovs.61.6.13.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"623_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/iovs.61.6.13","volume":"61","author":"K Itoh","year":"2020","unstructured":"Itoh K, Hikage F, Ida Y, Ohguro H. Prostaglandin F2\u03b1 agonists negatively modulate the size of 3D organoids from primary human orbital fibroblasts. Invest Ophthalmol Vis Sci. 2020;61:13. https:\/\/doi.org\/10.1167\/iovs.61.6.13.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"623_CR20","doi-asserted-by":"publisher","first-page":"9002","DOI":"10.1038\/s41598-021-88562-4","volume":"11","author":"K Itoh","year":"2021","unstructured":"Itoh K, Ida Y, Ohguro H, Hikage F. Prostaglandin F2\u03b1 agonists induced enhancement in collagen1 expression is involved in the pathogenesis of the deepening of upper eyelid sulcus. Sci Rep. 2021;11:9002. https:\/\/doi.org\/10.1038\/s41598-021-88562-4.","journal-title":"Sci Rep"},{"key":"623_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1210\/en.2018-00272","volume":"160","author":"F Hikage","year":"2019","unstructured":"Hikage F, Atkins S, Kahana A, Smith TJ, Chun TH. HIF2A-LOX pathway promotes fibrotic tissue remodeling in thyroid-associated orbitopathy. Endocrinology. 2019;160:20\u201335. https:\/\/doi.org\/10.1210\/en.2018-00272.","journal-title":"Endocrinology"},{"key":"623_CR22","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.1038\/s41598-020-64674-1","volume":"10","author":"Y Ida","year":"2020","unstructured":"Ida Y, Hikage F, Itoh K, Ida H, Ohguro H. Prostaglandin F2\u03b1 agonist-induced suppression of 3T3-L1 cell adipogenesis affects spatial formation of extra-cellular matrix. Sci Rep. 2020;10:7958. https:\/\/doi.org\/10.1038\/s41598-020-64674-1.","journal-title":"Sci Rep"},{"key":"623_CR23","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/s41598-020-72538-x","volume":"10","author":"Y Ida","year":"2020","unstructured":"Ida Y, Hikage F, Umetsu A, Ida H, Ohguro H. Omidenepag, a non-prostanoid EP2 receptor agonist, induces enlargement of the 3D organoid of 3T3-L1 cells. Sci Rep. 2020;10:16018. https:\/\/doi.org\/10.1038\/s41598-020-72538-x.","journal-title":"Sci Rep"},{"key":"623_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10384-018-0566-9","volume":"62","author":"M Honjo","year":"2018","unstructured":"Honjo M, Tanihara H. Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma. Jpn J Ophthalmol. 2018;62:109\u201326. https:\/\/doi.org\/10.1007\/s10384-018-0566-9.","journal-title":"Jpn J Ophthalmol"},{"key":"623_CR25","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.4049\/jimmunol.1602142","volume":"198","author":"A Zanin-Zhorov","year":"2017","unstructured":"Zanin-Zhorov A, Weiss JM, Trzeciak A, Chen W, Zhang J, Nyuydzefe MS, Arencibia C, Polimera S, Schueller O, Fuentes-Duculan J, et al. Cutting edge: selective oral ROCK2 Inhibitor reduces clinical scores in patients with psoriasis vulgaris and normalizes skin pathology via concurrent regulation of IL-17 and IL-10. J Immunol. 2017;198:3809\u201314. https:\/\/doi.org\/10.4049\/jimmunol.1602142.","journal-title":"J Immunol"},{"key":"623_CR26","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.26355\/eurrev_201809_15834","volume":"22","author":"Y Xie","year":"2018","unstructured":"Xie Y, Song T, Huo M, Zhang Y, Zhang YY, Ma ZH, Wang N, Zhang JP, Chu L. Fasudil alleviates hepatic fibrosis in type 1 diabetic rats: involvement of the inflammation and RhoA\/ROCK pathway. Eur Rev Med Pharmacol Sci. 2018;22:5665\u201377. https:\/\/doi.org\/10.26355\/eurrev_201809_15834.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"623_CR27","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1021\/acs.jmedchem.5b00683","volume":"59","author":"Y Feng","year":"2016","unstructured":"Feng Y, LoGrasso PV, Defert O, Li R. Rho kinase (ROCK) inhibitors and their therapeutic potential. J Med Chem. 2016;59:2269\u2013300. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00683.","journal-title":"J Med Chem"},{"key":"623_CR28","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1038\/s41598-018-20821-3","volume":"8","author":"DTV Diep","year":"2018","unstructured":"Diep DTV, Hong K, Khun T, Zheng M, Ul-Haq A, Jun HS, Kim YB, Chun KH. Anti-adipogenic effects of KD025 (SLx-2119), a ROCK2-specific inhibitor, in 3T3-L1 cells. Sci Rep. 2018;8:2477. https:\/\/doi.org\/10.1038\/s41598-018-20821-3.","journal-title":"Sci Rep"},{"key":"623_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3109\/02713683.2012.733055","volume":"38","author":"LK Seibold","year":"2013","unstructured":"Seibold LK, Ammar DA, Kahook MY. Acute effects of glaucoma medications and benzalkonium chloride on pre-adipocyte proliferation and adipocyte cytotoxicity in vitro. Curr Eye Res. 2013;38:70\u20134. https:\/\/doi.org\/10.3109\/02713683.2012.733055.","journal-title":"Curr Eye Res"},{"key":"623_CR30","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1167\/iovs.13-12589","volume":"55","author":"Y Taketani","year":"2014","unstructured":"Taketani Y, Yamagishi R, Fujishiro T, Igarashi M, Sakata R, Aihara M. Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy. Invest Ophthalmol Vis Sci. 2014;55:1269\u201376. https:\/\/doi.org\/10.1167\/iovs.13-12589.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"623_CR31","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1101\/gad.14.11.1293","volume":"14","author":"ED Rosen","year":"2000","unstructured":"Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. Transcriptional regulation of adipogenesis. Genes Dev. 2000;14:1293\u2013307.","journal-title":"Genes Dev"},{"key":"623_CR32","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1073\/pnas.0400356101","volume":"101","author":"T Imai","year":"2004","unstructured":"Imai T, Takakuwa R, Marchand S, Dentz E, Bornert JM, Messaddeq N, Wendling O, Mark M, Desvergne B, Wahli W, et al. Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc Natl Acad Sci U S A. 2004;101:4543\u20137. https:\/\/doi.org\/10.1073\/pnas.0400356101.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"623_CR33","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrm3198","volume":"12","author":"AG Cristancho","year":"2011","unstructured":"Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol. 2011;12:722\u201334. https:\/\/doi.org\/10.1038\/nrm3198.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"623_CR34","doi-asserted-by":"publisher","first-page":"29574","DOI":"10.1074\/jbc.M705972200","volume":"282","author":"M Noguchi","year":"2007","unstructured":"Noguchi M, Hosoda K, Fujikura J, Fujimoto M, Iwakura H, Tomita T, Ishii T, Arai N, Hirata M, Ebihara K, et al. Genetic and pharmacological inhibition of Rho-associated kinase II enhances adipogenesis. J Biol Chem. 2007;282:29574\u201383. https:\/\/doi.org\/10.1074\/jbc.M705972200.","journal-title":"J Biol Chem"},{"key":"623_CR35","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1210\/me.2002-0040","volume":"17","author":"I Ahmed","year":"2003","unstructured":"Ahmed I, Gesty-Palmer D, Drezner MK, Luttrell LM. Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts. Mol Endocrinol (Baltimore, Md). 2003;17:1607\u201321.","journal-title":"Mol Endocrinol (Baltimore, Md.)"},{"key":"623_CR36","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1210\/en.2005-0804","volume":"146","author":"HN Jabbour","year":"2005","unstructured":"Jabbour HN, Sales KJ, Boddy SC, Anderson RA, Williams AR. A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2alpha synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1\/2 signaling pathway. Endocrinology. 2005;146:4657\u201364. https:\/\/doi.org\/10.1210\/en.2005-0804.","journal-title":"Endocrinology"},{"key":"623_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mce.2008.01.016","volume":"285","author":"KJ Sales","year":"2008","unstructured":"Sales KJ, Grant V, Jabbour HN. Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element. Mol Cell Endocrinol. 2008;285:51\u201361. https:\/\/doi.org\/10.1016\/j.mce.2008.01.016.","journal-title":"Mol Cell Endocrinol"},{"key":"623_CR38","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1111\/j.1742-4658.2011.08213.x","volume":"278","author":"T Ueno","year":"2011","unstructured":"Ueno T, Fujimori K. Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2\u03b1 receptor mediated activation of MEK\/ERK-CREB cascade. Febs j. 2011;278:2901\u201312. https:\/\/doi.org\/10.1111\/j.1742-4658.2011.08213.x.","journal-title":"Febs j"},{"key":"623_CR39","doi-asserted-by":"publisher","first-page":"25624","DOI":"10.1074\/jbc.M110.115196","volume":"285","author":"E Goupil","year":"2010","unstructured":"Goupil E, Tassy D, Bourguet C, Quiniou C, Wisehart V, P\u00e9trin D, Le Gouill C, Devost D, Zingg HH, Bouvier M, et al. A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2alpha-mediated Rho\/ROCK signaling pathway. J Biol Chem. 2010;285:25624\u201336. https:\/\/doi.org\/10.1074\/jbc.M110.115196.","journal-title":"J Biol Chem"},{"key":"623_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066017","volume":"8","author":"K Aihara","year":"2013","unstructured":"Aihara K, Handa T, Oga T, Watanabe K, Tanizawa K, Ikezoe K, Taguchi Y, Sato H, Chin K, Nagai S, et al. Clinical relevance of plasma prostaglandin F2alpha metabolite concentrations in patients with idiopathic pulmonary fibrosis. PLoS ONE. 2013;8: e66017. https:\/\/doi.org\/10.1371\/journal.pone.0066017.","journal-title":"PLoS ONE"},{"key":"623_CR41","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/nm.2066","volume":"15","author":"T Oga","year":"2009","unstructured":"Oga T, Matsuoka T, Yao C, Nonomura K, Kitaoka S, Sakata D, Kita Y, Tanizawa K, Taguchi Y, Chin K, et al. Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta. Nat Med. 2009;15:1426\u201330. https:\/\/doi.org\/10.1038\/nm.2066.","journal-title":"Nat Med"},{"key":"623_CR42","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/nm1209-1360","volume":"15","author":"MA Olman","year":"2009","unstructured":"Olman MA. Beyond TGF-beta: a prostaglandin promotes fibrosis. Nat Med. 2009;15:1360\u20131. https:\/\/doi.org\/10.1038\/nm1209-1360.","journal-title":"Nat Med"},{"key":"623_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.593874","volume":"8","author":"C Onursal","year":"2021","unstructured":"Onursal C, Dick E, Angelidis I, Schiller HB, Staab-Weijnitz CA. Collagen biosynthesis, processing, and maturation in lung ageing. Front Med. 2021;8: 593874. https:\/\/doi.org\/10.3389\/fmed.2021.593874.","journal-title":"Front Med"},{"key":"623_CR44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1091\/mbc.e06-08-0684","volume":"18","author":"A Yoneda","year":"2007","unstructured":"Yoneda A, Ushakov D, Multhaupt HA, Couchman JR. Fibronectin matrix assembly requires distinct contributions from Rho kinases I and -II. Mol Biol Cell. 2007;18:66\u201375. https:\/\/doi.org\/10.1091\/mbc.e06-08-0684.","journal-title":"Mol Biol Cell"},{"key":"623_CR45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1083\/jcb.141.2.539","volume":"141","author":"C Zhong","year":"1998","unstructured":"Zhong C, Chrzanowska-Wodnicka M, Brown J, Shaub A, Belkin AM, Burridge K. Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J Cell Biol. 1998;141:539\u201351. https:\/\/doi.org\/10.1083\/jcb.141.2.539.","journal-title":"J Cell Biol"},{"key":"623_CR46","first-page":"137","volume":"42","author":"M Honjo","year":"2001","unstructured":"Honjo M, Tanihara H, Inatani M, Kido N, Sawamura T, Yue BYJT, Narumiya S, Honda Y. Effects of Rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility. Invest Ophthalmol Vis Sci. 2001;42:137\u201344.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"623_CR47","first-page":"1029","volume":"42","author":"PV Rao","year":"2001","unstructured":"Rao PV, Deng P-F, Kumar J, Epstein DL. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci. 2001;42:1029\u201337.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-021-00623-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-021-00623-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-021-00623-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T18:15:21Z","timestamp":1641406521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-021-00623-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["623"],"URL":"https:\/\/doi.org\/10.1007\/s13577-021-00623-y","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"assertion":[{"value":"11 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed at the Sapporo Medical University Hospital, Japan, was approved by the institutional review board (approved number, 312-3190) and according to the tenets of the Declaration of Helsinki as well as national laws for the protection of personal data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Yes.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}